$RGBP Upcoming milestones include new CRO confirmatory study results, animal studies, and an IND submission. The IND submission could lead to a Phase I clinical (human) trial in 18+ months.
Our 6-12-month price target is $5.00. This target represents a $17.5 million market cap
https://www.goldmanresearch.com/202310041385/...layer.html